Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK

International Journal of Molecular Medicine

Volumn 34, Issue 4, 2014, Pages 1081-1086

  Hu, Yan Jian ^a   Li, Hong Ying ^b   Qiu, Kai Jie ^a   Li, Da Chuan ^a   Zhou, Jia Hui ^c   Hu, Yan Hua ^a   Zhang, Feng Min ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^c LIAONING UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Invasion; Mechanism; Notch1; Small interfering RNA

Indexed keywords

FOCAL ADHESION KINASE; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL INTERFERING RNA; NOTCH RECEPTOR; PTEN PROTEIN, HUMAN;

ARTICLE; CARCINOMA CELL LINE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; MHCC97H CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR INVASION; CELL MOTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84907476162     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1889     Document Type: Article

References (32)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Marquardt JU, Galle PR and Teufel A: Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol 56: 267-275, 2012.
3. Wang YH, Dong YY, Wang WM, et al: Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines. J Exp Clin Cancer Res 32: 51, 2013.
4. Chen JS, Huang XH, Wang Q, et al: Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis 34: 10-19, 2013.
5. Liu L, Dai Y, Chen J, et al: Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. Hepatology 59: 531-543, 2014.
6. Bolós V, Grego-Bessa J and de la Pompa J L: Notch signaling in development and cancer. Endocr Rev 28: 339-363, 2007. (Pubitemid 46984831)
7. Hu YY, Zheng MH, Zhang R, Liang YM and Han H: Notch signaling pathway and cancer metastasis. Adv Exp Med Biol 727: 186-198, 2012.
8. Wang X Q, Zhang W, Lui E L, et al: Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer 131: E163-E172, 2012.
9. Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and Dou KF: Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor. Oncol Rep 28: 874-882, 2012.
10. Ahn S, Hyeon J and Park C K: Notchl and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 12: 286-294, 2013.
11. Fox V, Gokhale PJ, Walsh JR, Matin M, Jones M and Andrews PW: Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation. Stem Cells 26: 715-723, 2008.
12. Singh G and Chan AM: Post-translational modifications of PTEN and their potential therapeutic implications. Curr Cancer Drug Targets 11: 536-547, 2011.
13. Golubovskaya VM: Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med Chem 10: 735-741, 2010.
14. Zhang L, Yu Q, He J and Zha X: Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines. Mol Cell Biochem 262: 25-33, 2004. (Pubitemid 39158051)
15. Wong R, Frenette C and Gish R: Hepatocellular carcinoma: locoregional and targeted therapies. Gastroenterol Clin North Am 40: 599-610, 2011.
16. Silva A, Jotta P Y, Silveira A B, et al: Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2-and γ-secretase inhibitors. Haematologica 95: 674-678, 2010.
17. Palomero T, Sulis ML, Cortina M, et al: Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13: 1203-1210, 2007. (Pubitemid 47530629)
18. Wang L, Wang WL, Zhang Y, Guo SP, Zhang J and Li QL: Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res 37: 389-396, 2007. (Pubitemid 46605424)
19. Chow LM and Baker SJ: PTEN function in normal and neoplastic growth. Cancer Lett 241: 184-196, 2006. (Pubitemid 44163047)
20. Hu TH, Huang CC, Lin PR, et al: Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97: 1929-1940, 2003.
21. Dong-Dong L, Xi-Ran Z and Xiang-Rong C: Expression and significance of new tumor suppressor gene PTEN in primary liver cancer. J Cell Mol Med 7: 67-71, 2003. (Pubitemid 37123378)
22. Thanapprapasr D, Hu W, Sood AK and Coleman RL: Moving beyond VEGF for anti-angiogenesis strategies in g ynecologic cancer. Curr Pharm Des 18: 2713-2719, 2012.
23. Bai X, Wang J, Zhang L, et al: Prostaglandin E 2 receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells. Int J Oncol 42: 1833-1841, 2013.
24. Zhang C, He H, Zhang H, et al: The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells. Biochem Biophys Res Commun 434: 35-41, 2013.
25. Chen JS, Huang XH, Wang Q, et al: FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 27: 71-82, 2010.
26. Lau GM, Lau GM, Yu GL, et al: Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro. Dig Dis Sci 54: 1465-1474, 2009.
27. Han S, Han L, Yao Y, Sun H, Zan X and Liu Q: Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling. Oncol Rep 31: 641-648, 2014.
28. Ko BS, Jan YJ, Chang TC, et al: Upregulation of focal adhesion kipsinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma. Anticancer Agents Med Chem 13: 555-562, 2013.
29. Sheng SL, Liu JJ, Dai YH, Sun XG, Xiong XP and Huang G: Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J 279: 3898-3910, 2012.
30. Xu HY, Qian AR, Shang P, et al: siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway. Cancer Lett 247: 336-344, 2007. (Pubitemid 46240626)
31. Chetram MA and Hinton CV: PTEN regulation of ERK1/2 signaling in cancer. J Recept Signal Transduct Res 32: 190-195, 2012.
32. Tamura M, Gu J, Danen E H J, et al: PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274: 20693-20703, 1999.